SMTL ID : 3et7.1

Crystal structure of PYK2 complexed with PF-2318841

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.70 Å

Oligo State

monomer

Ligands

1 x 349: 5-{[4-{[2-(pyrrolidin-1-ylsulfonyl)benzyl]amino}-5-(trifluoromethyl)pyrimidin-2-yl]amino}-1,3-dihydro-2H-indol-2-one(Non-covalent)

349.1: 14 residues within 4Å: Chain A: L.16, G.17, E.18, V.24, A.40, V.72, M.87, E.88, L.89, Y.90, G.93, E.94, R.138, L.141 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:E.94, A:L.141, A:L.141 Hydrogen bonds: A:Y.90, A:Y.90 Salt bridges: A:E.94

1 x PO4: PHOSPHATE ION(Non-functional Binders)

PO4.2: 3 residues within 4Å: Chain A: P.69, H.70, K.120 2 PLIP interactions: 2 interactions with chain A Salt bridges: A:H.70, A:K.120

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Walker, D.P. et al., Trifluoromethylpyrimidine-based inhibitors of proline-rich tyrosine kinase 2 (PYK2): structure-activity relationships and strategies for the elimination of reactive metabolite formation. Bioorg.Med.Chem.Lett. (2008)

Release Date

2009-06-23

Peptides

Protein tyrosine kinase 2 beta: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Protein tyrosine kinase 2 beta

Related Entries With Identical Sequence